Biocept Signs CNSide™ Licensing Agreement
VIP LIVEALERTS-PRO Biocept Signs CNSide™ Licensing Agreement Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics September 08, 2023 08:00 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing agreement for CNSide™ with Plus Therapeutics, Inc. (Nasdaq: PSTV) […]
Taysha gene therapies reports initial clinical data
VIP LIVEALERTS-PRO Taysha Gene Therapies, Inc Taysha gene therapies reports initial clinical data from first adult rett syndrome patient dosed in reveal phase 1/2 trial and provides corporate update with second quarter 2023 financial results Data from first adult patient dosed in REVEAL Phase 1/2 trial showed TSHA-102 was well-tolerated with no treatment-emergent serious adverse […]
Walgreens Boots Alliance Sells Remaining Shares
VIP LIVEALERTS-PRO Walgreens Boots Alliance Walgreens Boots Alliance Sells Remaining Shares of Option Care Health for Approximately $330 Million of Proceeds Transaction Highlights Walgreens Boots Alliance announces the sale of its remaining shares of Option Care Health for proceeds of approximately $330 million Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown, […]
Sunshine Biopharma Reports 2023 First Quarter: Revenues Up 2,100%
VIP LIVEALERTS-PRO Sunshine Biopharma Revenues Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100% MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2023 first quarter report. […]
Aclarion skyrockets 197% after positive trial data
VIP LIVEALERTS-PRO Aclarion Groundbreaking Clinical Trial Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial Apr. 24, 2023 7:00 AM ET Source: Aclarion, Inc. Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent with Nociscan-identified discs, a 22 percentage point improvement over patients whose […]
Leading-Edge Science: Merck and Ridgeback Provide Update
VIP LIVEALERTS-PRO Leading-Edge Science News Leading-Edge Science: Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO™ (Molnupiravir) RAHWAY, N.J. & MIAMI–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines […]
Sera Prognostics Announces Positive Top-line Data
VIP LIVEALERTS-PRO Sera Prognostics Positive Data Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL PreTRM® test-and-treat strategy demonstrates statistically and clinically significant improvement in neonatal health outcomes and hospital length-of-stay SALT LAKE CITY, Feb. 15, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker […]